Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061445611> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2061445611 endingPage "92" @default.
- W2061445611 startingPage "88" @default.
- W2061445611 abstract "Traditionally, the neuropsychiatric symptoms of Alzheimer's disease (AD) have been managed with neuroleptics or benzodiazepines, which have serious side effects. Preliminary observations suggest the possible value of cholinesterase inhibitors in the amelioration of psychotic symptoms in patients with dementia of the Alzheimer's type, dementia with Lewy bodies, and in patients with Parkinson's disease. Twelve inpatients with AD with psychotic symptoms and lack of improvement of their delusions/hallucinations during perphenazine treatment (8 mg/day) for 3 weeks received random open-label donepezil 5 mg daily in addition to an ongoing treatment of 8 mg/day perphenazine or 16 mg/day perphenazine. Assessments conducted at baseline and after weeks 2 and 4 included the Mini-Mental State Examination, the Global Deterioration Scale, the Positive and Negative Symptoms Scale, and the Clinical Global Impressions scale. Frequency of extrapyramidal symptoms was measured according to the Abnormal Involuntary Movement Scale. The donepezil-perphenazine group exhibited substantially greater and clinical improvements in mental state. At the end of the trial (4 weeks), Positive and Negative Symptoms Scale scores revealed significant differences between both groups (p = 0.006). The Clinical Global Impressions scale and the Mini-Mental State Examination scores also showed significant differences between the donepezil-perphenazine group and the perphenazine group (p = 0.028 and p = 0.027 respectively). No significant differences were found in the Global Deterioration Scale scores. Abnormal Involuntary Movement Scale scores showed a significant deterioration in extrapyramidal symptoms in the perphenazine group compared with the donepezil-perphenazine group (p = 0.016). Donepezil augmentation of neuroleptics may be appropriate for those patients for whom neuroleptic monotherapy either does not lead to symptom remission or is associated with intolerable adverse effects. This was an open-label study and there is need for larger studies with double-blind control and a long-term study design to define the efficacy of donepezil for patients with AD and psychotic symptoms." @default.
- W2061445611 created "2016-06-24" @default.
- W2061445611 creator A5031650824 @default.
- W2061445611 creator A5044262660 @default.
- W2061445611 creator A5059532230 @default.
- W2061445611 creator A5064566770 @default.
- W2061445611 date "2003-03-01" @default.
- W2061445611 modified "2023-09-25" @default.
- W2061445611 title "Donepezil as Add-on Treatment of Psychotic Symptoms in Patients with Dementia of the Alzheimer's Type" @default.
- W2061445611 cites W1847168837 @default.
- W2061445611 cites W1972111813 @default.
- W2061445611 cites W1980525435 @default.
- W2061445611 cites W1984338522 @default.
- W2061445611 cites W1990848795 @default.
- W2061445611 cites W1991176470 @default.
- W2061445611 cites W2020476996 @default.
- W2061445611 cites W2024304708 @default.
- W2061445611 cites W2028980047 @default.
- W2061445611 cites W2030817295 @default.
- W2061445611 cites W2044337871 @default.
- W2061445611 cites W2046427207 @default.
- W2061445611 cites W2055727638 @default.
- W2061445611 cites W2059729306 @default.
- W2061445611 cites W2062825859 @default.
- W2061445611 cites W2067418199 @default.
- W2061445611 cites W2081285591 @default.
- W2061445611 cites W2100357433 @default.
- W2061445611 cites W2101970501 @default.
- W2061445611 cites W2112549296 @default.
- W2061445611 cites W2116249921 @default.
- W2061445611 doi "https://doi.org/10.1097/00002826-200303000-00008" @default.
- W2061445611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12671528" @default.
- W2061445611 hasPublicationYear "2003" @default.
- W2061445611 type Work @default.
- W2061445611 sameAs 2061445611 @default.
- W2061445611 citedByCount "30" @default.
- W2061445611 countsByYear W20614456112012 @default.
- W2061445611 countsByYear W20614456112015 @default.
- W2061445611 countsByYear W20614456112016 @default.
- W2061445611 countsByYear W20614456112018 @default.
- W2061445611 countsByYear W20614456112019 @default.
- W2061445611 countsByYear W20614456112020 @default.
- W2061445611 countsByYear W20614456112022 @default.
- W2061445611 crossrefType "journal-article" @default.
- W2061445611 hasAuthorship W2061445611A5031650824 @default.
- W2061445611 hasAuthorship W2061445611A5044262660 @default.
- W2061445611 hasAuthorship W2061445611A5059532230 @default.
- W2061445611 hasAuthorship W2061445611A5064566770 @default.
- W2061445611 hasConcept C118552586 @default.
- W2061445611 hasConcept C126322002 @default.
- W2061445611 hasConcept C15744967 @default.
- W2061445611 hasConcept C2776412080 @default.
- W2061445611 hasConcept C2776743534 @default.
- W2061445611 hasConcept C2779077818 @default.
- W2061445611 hasConcept C2779134260 @default.
- W2061445611 hasConcept C2779483572 @default.
- W2061445611 hasConcept C2780494398 @default.
- W2061445611 hasConcept C2780616385 @default.
- W2061445611 hasConcept C2780904820 @default.
- W2061445611 hasConcept C42219234 @default.
- W2061445611 hasConcept C502032728 @default.
- W2061445611 hasConcept C71924100 @default.
- W2061445611 hasConceptScore W2061445611C118552586 @default.
- W2061445611 hasConceptScore W2061445611C126322002 @default.
- W2061445611 hasConceptScore W2061445611C15744967 @default.
- W2061445611 hasConceptScore W2061445611C2776412080 @default.
- W2061445611 hasConceptScore W2061445611C2776743534 @default.
- W2061445611 hasConceptScore W2061445611C2779077818 @default.
- W2061445611 hasConceptScore W2061445611C2779134260 @default.
- W2061445611 hasConceptScore W2061445611C2779483572 @default.
- W2061445611 hasConceptScore W2061445611C2780494398 @default.
- W2061445611 hasConceptScore W2061445611C2780616385 @default.
- W2061445611 hasConceptScore W2061445611C2780904820 @default.
- W2061445611 hasConceptScore W2061445611C42219234 @default.
- W2061445611 hasConceptScore W2061445611C502032728 @default.
- W2061445611 hasConceptScore W2061445611C71924100 @default.
- W2061445611 hasIssue "2" @default.
- W2061445611 hasLocation W20614456111 @default.
- W2061445611 hasLocation W20614456112 @default.
- W2061445611 hasOpenAccess W2061445611 @default.
- W2061445611 hasPrimaryLocation W20614456111 @default.
- W2061445611 hasRelatedWork W111364964 @default.
- W2061445611 hasRelatedWork W1965055466 @default.
- W2061445611 hasRelatedWork W2005609961 @default.
- W2061445611 hasRelatedWork W2033667544 @default.
- W2061445611 hasRelatedWork W2053130427 @default.
- W2061445611 hasRelatedWork W2061445611 @default.
- W2061445611 hasRelatedWork W2124088010 @default.
- W2061445611 hasRelatedWork W2418519332 @default.
- W2061445611 hasRelatedWork W2748952813 @default.
- W2061445611 hasRelatedWork W2899084033 @default.
- W2061445611 hasVolume "26" @default.
- W2061445611 isParatext "false" @default.
- W2061445611 isRetracted "false" @default.
- W2061445611 magId "2061445611" @default.
- W2061445611 workType "article" @default.